Anderson Raymond
SEC CIK 1362489 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | Dir | 8,515 | — | $703.0K | 14 | 2021-06-30 | 2026-08-25 |
Most active insiders at MNPR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Tsuchimoto Kim R | Dir | — | $911.1K |
| 2 | Anderson Raymond | Dir | — | $703.0K |
| 3 | KLAUSNER ARTHUR J | Dir | — | $343.9K |
| 4 | Vu Quan Anh | CFO | $104.9K | — |
| 5 | RIOUX PATRICE | Acting Chief Medical Off | — | $111.26 |
| 6 | Cittadine Andrew | COO | — | — |
| 7 | Hendricks Diane | 10% | — | — |
| 8 | Robinson Chandler | CEO, Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMAT | 2026-08-28 19:41 | 2026-08-25 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | $30.00 | +3,142 | 8,515 | +58% | +$94.3K |
| DMAT | 2026-08-28 19:41 | 2026-08-25 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | S - Sale+OE | $111.98 | -3,142 | 5,373 | -37% | -$351.8K |
| MT | 2026-08-27 18:27 | 2026-08-25 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | S - Sale | $111.77 | -3,142 | 23.8K | -12% | -$351.2K |
| D | 2024-01-03 | 2023-12-31 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | — | +2,533 | 26.9K | +10% | — |
| D | 2023-10-03 | 2023-09-30 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | — | +2,533 | 24.3K | +12% | — |
| D | 2023-07-03 | 2023-06-30 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | — | +2,534 | 21.8K | +13% | — |
| D | 2023-04-04 | 2023-03-31 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | — | +2,533 | 19.3K | +15% | — |
| D | 2023-01-03 | 2022-12-31 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | — | +2,859 | 16.7K | +21% | — |
| D | 2022-10-03 | 2022-09-30 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | — | +2,859 | 13.9K | +26% | — |
| D | 2022-07-01 | 2022-06-30 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | — | +2,859 | 11.0K | +35% | — |
| D | 2022-04-01 | 2022-03-31 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | — | +2,859 | 8,153 | +54% | — |
| D | 2022-01-04 | 2021-12-31 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | — | +751 | 5,294 | +17% | — |
| D | 2021-10-01 | 2021-09-30 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | — | +751 | 4,543 | +20% | — |
| D | 2021-07-02 | 2021-06-30 | MNPR | Monopar Therapeutics | Anderson Raymond | Dir | M - OptEx | — | +752 | 3,792 | +25% | — |
Purchase Sale Sale after option exercise All abbreviations